Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL27551880 | 0.98 | HSD17B10 (0.50) | HSD17B10ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL27613328 | 0.93 | HSD17B10 (0.46) | HSD17B10ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL319113 | 0.83 | HSD17B10 (0.52) | HSD17B10ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL8568179 | 0.80 | ALDH1A1 (0.53) | ALDH1A1MAPTMEN1KMT2ATSHR | |
| Ethylene SCHEMBL27749109 | 0.80 | HSD17B10 (0.48) | HSD17B10ALDH1A1MAPTMEN1KMT2A | |
| Ethylene SCHEMBL27749127 | 0.77 | ALDH1A1 (0.50) | ALDH1A1MAPTMEN1KMT2ATSHR | |
| SCHEMBL13483429 | 0.76 | MAPT (0.52) | HSD17B10ALDH1A1MAPTMEN1KMT2A | |
| Acetic Acid SCHEMBL28009360 | 0.76 | TSHR (0.47) | HSD17B10ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL5700402 | 0.75 | ALDH1A1 (0.45) | ALDH1A1MAPTMEN1KMT2ARAB9A | |
| SCHEMBL1284068 | 0.75 | MAPT (0.53) | ALDH1A1MAPTMEN1KMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108178248-A | The graphite electrode modified based on CuO-CoO-ZnO and pyridine | 光合强化（北京）生物科技有限公司 | 2018-06-19 | — | — | CN | claimed |
| CN-103421004-A | 5-azaindole preparation method | ASCEPION PHARMACEUTICALS INC | 2013-12-04 | — | — | CN | claimed |
| JP-4691506-B2 | — | — | 2011-06-01 | — | — | JP | claimed |
| EP-1747220-B1 | SUBSTITUTED 1H-PYRROLO[3,2-B, 3,2-C, AND 2,3-C]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I EPSILON | AVENTIS PHARMA INC (US) | 2009-04-15 | — | — | EP | claimed |
| CN-100439367-C | Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon | AVENTIS PHARMA INC (US) | 2008-12-03 | — | — | CN | claimed |
| US-20080200496-A1 | SUBSTITUTED 1H-PYRROLO[3,2-b, 3,2-c, and 2,3-c]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE Ie | AVENTIS PHARMACEUTICALS INC. (US) | 2008-08-21 | — | — | US | claimed |
| CN-1321118-C | Process for the preparation of 5-azaindoles | UNIV ZHEJIANG (CN) | 2007-06-13 | — | — | CN | claimed |
| EP-1747220-A1 | SUBSTITUTED 1H-PYRROLO 3,2-B, 3,2-C, AND 2,3-C¨PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I EPSILON | Aventis Pharmaceuticals Inc. (US) | 2007-01-31 | — | — | EP | claimed |
| CN-1906194-A | Substituted 1H-pyrrolo [3, 2-b, 3, 2-c and 2, 3-c ] pyridine-2-carboxamides and related analogs as inhibitors of casein kinase ie | AVENTIS PHARMA INC (US) | 2007-01-31 | — | — | CN | claimed |
| CN-1730481-A | Process for the preparation of 5-azaindoles | UNIV ZHEJIANG (CN) | 2006-02-08 | — | — | CN | claimed |
| WO-2005061498-A1 | SUBSTITUTED 1H-PYRROLO[3,2-B, 3,2-C, AND 2,3-C]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I EPSILON | AVENTIS PHARMACEUTICALS INC. (US) | 2005-07-07 | — | — | WO | claimed |
| US-20050131012-A1 | Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon | AVENTIS PHARMACEUTICALS INC. (US) | 2005-06-16 | — | — | US | claimed |
| WO-2002006890-A2 | METHOD FOR PRODUCING NON-LINEAR OPTICAL ORGANIC CRYSTAL FILM | REVEO, INC. (US) | 2002-01-24 | — | — | WO | claimed |
| EP-0232138-B1 | POLYMER COMPOSITES | The British Petroleum Company p.l.c. (GB) | 1993-01-20 | — | — | EP | claimed |
| WO-2025111547-A1 | 2,3-DIHYDROPYROLLOPYRIDINE CARBOXAMIDE COMPOUNDS AND METHODS OF USE THEREOF | RGENTA THERAPEUTICS, INC. (US) | 2025-05-30 | — | — | WO | disclosed |
| CN-117510404-A | Preparation method of 4-aminonicotinic acid | 山西永津集团有限公司 | 2024-02-06 | — | — | CN | disclosed |
| US-20230225201-A1 | Organic Light Emitting Diode and Device Comprising the Same | NOVALED GMBH (DE) | 2023-07-13 | — | — | US | disclosed |
| US-20050131012-A1 | Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon | AVENTIS PHARMACEUTICALS INC. (US) | 2005-06-16 | — | — | US | disclosed |
| US-5633043-A | Process for fabricating thin films | RESEARCH DEVELOPMENT CORPORATION OF JAPAN (JP) | 1997-05-27 | — | — | US | disclosed |
| US-4625033-A | 3-METHYL-4-NITROPYRIDINE-1-OXIDE CONDENSED TO ENAMINE, CATALYTIC REDUCTION CYCLIZATION | SANOFI (FR) | 1986-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200496-A1 | SUBSTITUTED 1H-PYRROLO[3,2-b, 3,2-c, and 2,3-c]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE Ie | CSNK1E, CSNK1G3, CSNK2A3 | HSD17B10 3528/4885ALDH1A1 3613/4885MAPT 712/4885 |
| US-20050131012-A1 | Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon | CSNK2A3, PACSIN2, CSNK1G3 | HSD17B10 2865/4885ALDH1A1 4044/4885MAPT 1323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.